CD274 and neoplasm: It has been shown that tumour cells may escape from the immune surveillance by activating the CTLA-4B7 (B7 being the ligand of CTLA-4) and PD-1/PDL-1 checkpoint signalling pathways, which in turn suppress the CD8+ cytotoxic T-cell immune response [5].